Andy Batts
Long only, value, growth, momentum

Why Orthofix Is Grossly Undervalued And Worth Looking Into

Shares of Netherlands-based Orthofix International N.V. (NASDAQ:OFIX), a diversified global medical device company focused on developing and delivering innovative orthopedic solutions, have seen precipitous drop in price due to some company-specific issues and an unusual decline in Q1, 2013 gross margin. Currently the shares are trading around $20, near four-year lows.

Orthofix has a robust balance sheet, a unique product portfolio and a new management team, which I believe will help the company to stage a turnaround as early as next year. I believe that the correction offers an excellent investing opportunity for the medium-term with ~60% upside potential.

Company Overview

Orthofix is a diversified medical device company focused on developing and delivering innovative orthopedic solutions for patients,

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details